In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year’s meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and future of the cancer experience. Touching on areas like advocacy, AI, screening and therapeutic advances, this can’t miss conversation will help us envision a more effective and compassionate future in oncology. The Art: The art of improving patient care. How industry collaborations, data-based messaging and campaigns and advocacy are helping to reach more patients earlier and more holistically. Ysabel Duron, Founder, President / Executive Director, The Latino Cancer Institute Meredith Owen, Chief Revenue Officer, Analytics & Insights Group, Real Chemistry Shanthi Sivendran, MD, MSCR, MBA, Senior Vice President, Cancer Care Support, American Cancer Society Jewel Jones, Global Inclusion & Health Equity Practice Leader, Real Chemistry The Science: The latest therapeutics advancements in oncology. How technology is helping industry better engage providers and democratize science via visualization to help improve outcomes. HP Balaji, Senior Medical Director and TA Head, Bladder Cancer, Johnson & Johnson Innovative Medicine Brandon Pletsch, President, Scientific Visualization and Exhibit Experience, Real Chemistry

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related